University of Texas MD Anderson Cancer Center
-
Health News
AACR: Trio of studies highlights promising early results with new cancer therapies and targets
[ad_1] Newswise — SAN DIEGO – Three early-phase clinical studies presented by researchers from The University of Texas MD Anderson…
Read More » -
Health News
AACR: Combination treatment is well-tolerated, shows antitumor effects in KRAS G12C-mutated metastatic colorectal cancer
[ad_1] ABSTRACT CT013 Newswise — SAN DIEGO ― Combining the KRAS G12C inhibitor adagrasib with the anti-EGFR antibody cetuximab demonstrated…
Read More » -
Health News
AACR: PARP1-selective inhibitor demonstrates early efficacy in breast cancers with DNA repair defects
[ad_1] ABSTRACT CT014 Newswise — SAN DIEGO – The first-in-class PARP1-selective inhibitor saruparib demonstrated encouraging early efficacy and a favorable…
Read More » -
Health News
AACR: Novel immunotherapies show promise for patients with kidney cancer and for solid organ transplant recipients with skin cancer
[ad_1] ABSTRACTS: CT002, CT003 Newswise — SAN DIEGO ― Researchers from The University of Texas MD Anderson Cancer Center presented…
Read More » -
Health News
AACR: MD Anderson’s Padmanee Sharma elected Fellow of the AACR Academy
[ad_1] Newswise — Padmanee Sharma, M.D., Ph.D., associate vice president of Immunobiology, professor of Genitourinary Medical Oncology and Immunology, and…
Read More » -
Health News
Immunotherapy before surgery leads to promising long-term survival in sarcoma patients
[ad_1] Newswise — Patients with soft-tissue sarcoma treated with neoadjuvant, or pre-surgical, immunotherapy had very little residual tumor at the…
Read More » -
Health News
MD Anderson and C-Biomex sign collaborative research agreement to co-develop CBT-001 radioligand therapy
[ad_1] Newswise — HOUSTON & POHANG, South Korea – The University of Texas MD Anderson Cancer Center and C-Biomex Ltd. today…
Read More » -
Health News
MD Anderson Research Highlights for January 25, 2024
[ad_1] Newswise — HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Read More » -
Health News
CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies
[ad_1] Newswise — HOUSTON ― Researchers from The University of Texas MD Anderson Cancer Center reported promising results in a…
Read More » -
Health News
ASH: Mantle cell lymphoma patients see improved outcomes with oral combination of ibrutinib and venetoclax
[ad_1] ABSTRACT: LBA-2 Newswise — SAN DIEGO ― The targeted therapy combination of ibrutinib and venetoclax significantly improved progression-free survival…
Read More »